DK1175902T3 - Anvendelse CS-866 (olmesartan) til fremstillingen af et medikament til behandling af arteriosclerose - Google Patents
Anvendelse CS-866 (olmesartan) til fremstillingen af et medikament til behandling af arterioscleroseInfo
- Publication number
- DK1175902T3 DK1175902T3 DK01124669T DK01124669T DK1175902T3 DK 1175902 T3 DK1175902 T3 DK 1175902T3 DK 01124669 T DK01124669 T DK 01124669T DK 01124669 T DK01124669 T DK 01124669T DK 1175902 T3 DK1175902 T3 DK 1175902T3
- Authority
- DK
- Denmark
- Prior art keywords
- arteriosclerosis
- medicament
- treatment
- olmesartan
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18436896 | 1996-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1175902T3 true DK1175902T3 (da) | 2005-12-19 |
Family
ID=16152008
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01124669T DK1175902T3 (da) | 1996-07-15 | 1997-07-11 | Anvendelse CS-866 (olmesartan) til fremstillingen af et medikament til behandling af arteriosclerose |
DK97930762T DK0930076T3 (da) | 1996-07-15 | 1997-07-11 | Farmaceutiske præparater omfattende CS-866 og insulinresistensforbedrende midler og deres anvendelse i behandlingen af arteriosclerose og xanthom |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97930762T DK0930076T3 (da) | 1996-07-15 | 1997-07-11 | Farmaceutiske præparater omfattende CS-866 og insulinresistensforbedrende midler og deres anvendelse i behandlingen af arteriosclerose og xanthom |
Country Status (19)
Country | Link |
---|---|
US (1) | US6610682B2 (ko) |
EP (2) | EP0930076B1 (ko) |
KR (1) | KR100540618B1 (ko) |
CN (2) | CN1221259C (ko) |
AT (2) | ATE306921T1 (ko) |
AU (1) | AU714618B2 (ko) |
CA (1) | CA2261040C (ko) |
CZ (2) | CZ300089B6 (ko) |
DE (2) | DE69734405T2 (ko) |
DK (2) | DK1175902T3 (ko) |
ES (2) | ES2232873T3 (ko) |
HK (1) | HK1020260A1 (ko) |
HU (2) | HU227399B1 (ko) |
IL (2) | IL128059A (ko) |
NO (2) | NO322314B1 (ko) |
NZ (1) | NZ333723A (ko) |
PT (1) | PT930076E (ko) |
RU (2) | RU2183128C2 (ko) |
WO (1) | WO1998002183A1 (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
EP1261373A2 (en) * | 1999-12-24 | 2002-12-04 | SmithKline Beecham plc | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
CA2405793A1 (en) * | 2000-04-12 | 2001-10-18 | Novartis Ag | Combination of organic compounds |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
WO2003013609A1 (en) * | 2001-08-03 | 2003-02-20 | Takeda Chemical Industries, Ltd. | Sustained-release medicines |
DE10300111A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
ME00479B (me) * | 2003-01-31 | 2011-10-10 | Daiichi Sankyo Co Ltd | Lijek za profilaksu i tretman arterioskleroze i hipertenzije |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
DE602005025755D1 (de) * | 2004-06-04 | 2011-02-17 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
RU2441653C2 (ru) * | 2005-05-31 | 2012-02-10 | Милан Лэборетериз, Инк. | Композиции, содержащие небиволол |
KR101384841B1 (ko) * | 2005-06-27 | 2014-04-15 | 다이이찌 산쿄 가부시키가이샤 | 안지오텐신 ⅱ 수용체 길항제 및 칼슘 채널 차단제를함유한 약학 제제 |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
NZ567092A (en) | 2005-10-04 | 2011-05-27 | Bayer Schering Pharma Ag | Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
TWI399223B (zh) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | 奧美沙坦酯及氨氯地平之固體劑型 |
US20090076104A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched losartan |
RU2011124948A (ru) * | 2008-11-19 | 2012-12-27 | Мериал Лимитед | Композиции, включающие 1-арилпиразол сам по себе или в комбинации с формамидином, для лечения паразитарных инфекций |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN107617107A (zh) * | 2017-09-18 | 2018-01-23 | 浙江大学 | 一种复方血管紧张素转换酶类抗瘢痕制剂 |
CN107648611A (zh) * | 2017-09-18 | 2018-02-02 | 浙江大学 | 复方血管紧张素转换酶类抗瘢痕外用制剂 |
CN110075304B (zh) * | 2019-05-29 | 2020-02-11 | 四川大学华西医院 | 一种治疗骨关节炎的药物组合物及其用途 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3536687A1 (de) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
US5231080A (en) | 1985-10-15 | 1993-07-27 | Hoechst Aktiengesellschaft | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
US5223522A (en) * | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
CA2016467A1 (en) * | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
DE3925759A1 (de) * | 1989-08-03 | 1991-02-07 | Thera Patent Verwaltungs Gmbh | Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe |
US5061694A (en) * | 1989-10-23 | 1991-10-29 | E. R. Squibb & Sons, Inc. | Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
CA2026686A1 (en) | 1989-10-30 | 1991-05-01 | Werner Tschollar | Method for preventing onset of type ii diabetes employing an ace inhibitor |
GB2241890A (en) | 1990-03-12 | 1991-09-18 | Squibb & Sons Inc | Preventing onset of or treating protein catabolism using an ace inhibitor |
US5298497A (en) | 1990-05-15 | 1994-03-29 | E. R. Squibb & Sons, Inc. | Method for preventing onset of hypertension employing a cholesterol lowering drug |
US5616599A (en) | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
CA2229000C (en) * | 1991-02-21 | 2002-04-09 | Sankyo Company, Limited | 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
US5668117A (en) | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
WO1994001433A1 (en) * | 1992-07-13 | 1994-01-20 | Japan Tobacco Inc. | Novel thiazolidinedione compound and use thereof |
AU6114794A (en) * | 1993-02-24 | 1994-09-14 | Sankyo Company Limited | Arteriosclerosis remedy |
JPH0741423A (ja) | 1993-02-24 | 1995-02-10 | Sankyo Co Ltd | 動脈硬化症治療剤 |
IL113084A (en) * | 1994-03-23 | 1999-01-26 | Sankyo Co | Derivatives of thiazolidine and oxazolidine, processes for their preparation and pharmaceutical preparations containing them |
WO1995026188A1 (en) * | 1994-03-29 | 1995-10-05 | Merck & Co., Inc. | Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
DE69713890T3 (de) | 1996-04-05 | 2006-09-07 | Takeda Pharmaceutical Co. Ltd. | Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht |
-
1997
- 1997-07-11 CN CNB03136392XA patent/CN1221259C/zh not_active Expired - Lifetime
- 1997-07-11 EP EP97930762A patent/EP0930076B1/en not_active Expired - Lifetime
- 1997-07-11 DK DK01124669T patent/DK1175902T3/da active
- 1997-07-11 DK DK97930762T patent/DK0930076T3/da active
- 1997-07-11 DE DE69734405T patent/DE69734405T2/de not_active Expired - Lifetime
- 1997-07-11 EP EP01124669A patent/EP1175902B1/en not_active Expired - Lifetime
- 1997-07-11 AT AT01124669T patent/ATE306921T1/de active
- 1997-07-11 DE DE69731840T patent/DE69731840T2/de not_active Expired - Lifetime
- 1997-07-11 WO PCT/JP1997/002407 patent/WO1998002183A1/ja active IP Right Grant
- 1997-07-11 ES ES97930762T patent/ES2232873T3/es not_active Expired - Lifetime
- 1997-07-11 HU HU0600501A patent/HU227399B1/hu unknown
- 1997-07-11 CA CA002261040A patent/CA2261040C/en not_active Expired - Lifetime
- 1997-07-11 RU RU99103215/14A patent/RU2183128C2/ru active
- 1997-07-11 PT PT97930762T patent/PT930076E/pt unknown
- 1997-07-11 ES ES01124669T patent/ES2250283T3/es not_active Expired - Lifetime
- 1997-07-11 AT AT97930762T patent/ATE283704T1/de active
- 1997-07-11 RU RU2001126527/14A patent/RU2220723C2/ru active
- 1997-07-11 KR KR1019997000222A patent/KR100540618B1/ko not_active IP Right Cessation
- 1997-07-11 HU HU9903166A patent/HU225415B1/hu unknown
- 1997-07-11 AU AU34595/97A patent/AU714618B2/en not_active Expired
- 1997-07-11 IL IL12805997A patent/IL128059A/xx not_active IP Right Cessation
- 1997-07-11 NZ NZ333723A patent/NZ333723A/xx not_active IP Right Cessation
- 1997-07-11 CZ CZ20080174A patent/CZ300089B6/cs not_active IP Right Cessation
- 1997-07-11 CZ CZ0010299A patent/CZ299162B6/cs not_active IP Right Cessation
- 1997-07-11 CN CNB971979391A patent/CN1155409C/zh not_active Expired - Lifetime
-
1999
- 1999-01-14 NO NO19990166A patent/NO322314B1/no not_active IP Right Cessation
- 1999-11-22 HK HK99105398A patent/HK1020260A1/xx not_active IP Right Cessation
-
2001
- 2001-08-21 US US09/933,922 patent/US6610682B2/en not_active Expired - Lifetime
- 2001-10-04 IL IL145758A patent/IL145758A/en not_active IP Right Cessation
-
2005
- 2005-12-16 NO NO20056021A patent/NO334217B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1175902T3 (da) | Anvendelse CS-866 (olmesartan) til fremstillingen af et medikament til behandling af arteriosclerose | |
SE9604786D0 (sv) | New compounds | |
FR11C0038I1 (fr) | Analogues macrocycliques, leurs procedes d'utilisation et de preparation | |
MX9804597A (es) | Derivados de bencimidazol sustituidos por naftilo como anticoagulantes. | |
SE9504661D0 (sv) | New compounds | |
DE69626513T2 (de) | Imidazolverbindungen | |
CO4290432A1 (es) | Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos. | |
ATE369827T1 (de) | Wegwerfwindel | |
ATE243992T1 (de) | Kosmetische zusammensetzung und deren verwendung als hautreinigungsmaske | |
RU2001126527A (ru) | Средство и способ лечения или профилактики артериосклероза | |
DK0380331T3 (da) | Anvendelse af di-tert.butylhydroxyphenylthioderivater til fremstilling af et lægemiddel til behandling eller forebyggelse af arteriosklerose eller atherosklerose | |
ATE219073T1 (de) | Benzopyran derivate mit leukotrien- antagonistischer wirkung | |
FI851261L (fi) | Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
EP1057472A4 (en) | SOLID PREPARATION FOR ORAL HYGIENE | |
DK0750616T3 (da) | Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser | |
ES2091261T3 (es) | Utilizacion de un agente microbicida en la fabricacion de tejas de hormigon. | |
MX9102101A (es) | Composiciones que contienen psyllium. composiciones que contienen psyllium. | |
SE9504662D0 (sv) | New compounds | |
EP0338415A3 (en) | Use of sulphonylureas in the treatment of oedema | |
EE200300213A (et) | SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks | |
WO2002096901A3 (de) | 1,3-dihydroxybenzol-derivate und diese verbindungen enthaltende färbemittel | |
NO20026076D0 (no) | Kombinert terapi mot tumorer innbefattende substituerte akryloyldistamycinderivater, taksaner og/eller antimetabolitter | |
IT1265647B1 (it) | Composizione farmaceutiche topiche per le allergie respiratorie | |
DE69131058D1 (de) | Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis | |
NO995132L (no) | Fremgangsmåte for reduksjon av fibrinogen |